InvestorInvesting in private markets for over 30 years.
CTI Life Sciences Fund
CTI Life Sciences Fund is a Canadian venture capital firm specializing in investments in high-quality biotech companies at pre-clinical and clinical stages. The firm is headquartered in Montreal and focuses on transformative investments in the life sciences sector.
Online destinations
Find CTI Life Sciences Fund online
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Official links
Pages the organization runs itself.
Overview
CTI Life Sciences Fund is a venture capital firm founded in 2006 and based in Montreal, Quebec, Canada. The firm focuses on the biotechnology sector, aiming to catalyze transformative investments that support the development of innovative therapies and technologies. With a dual-pronged investment strategy, CTI invests in both early-stage and more advanced clinical-stage biotech companies, managing a diverse portfolio that emphasizes long-term value creation and expedited exit timelines. The firm is currently on its third fund, CTI LSF III, with total assets under management of $345 million CAD across three mandates.
Focus
The firm employs a dual-pronged investment strategy that emphasizes both long-term value creation and expedited exit timelines. CTI Life Sciences Fund invests in therapeutic and modality-agnostic biotech companies, managing a diverse portfolio that spans pre-clinical and clinical development stages.
Support
CTI Life Sciences Fund adds value to its portfolio companies through deep industry expertise, strategic guidance, and access to a robust network of partners and resources in the biotechnology sector. The team’s extensive experience in investment banking and biotech investing enables them to support companies in navigating the complexities of the biotech landscape.
Questions
What are CTI Life Sciences Fund's investment criteria?
CTI Life Sciences Fund invests in therapeutic and modality-agnostic biotech companies at various stages, including pre-seed, seed, Series A, Series B, and Series C. The firm seeks high-quality companies that demonstrate potential for scalable and marketable solutions.
How can startups apply or pitch to CTI Life Sciences Fund?
Startups interested in pitching to CTI Life Sciences Fund can visit their website at ctisciences.com for more information on the application process and to submit their proposals.
What makes CTI Life Sciences Fund different from other venture capital firms?
CTI Life Sciences Fund emphasizes a dual-pronged investment strategy that focuses on both long-term value creation and expedited exit timelines. This approach allows them to support companies effectively throughout their development stages.
What is the geographic scope of CTI Life Sciences Fund's investments?
The firm primarily invests in North America, with a strong focus on Canada. Approximately two-thirds of their investments are in Canadian companies, while the remaining third includes opportunities in the US and Europe.
What kind of post-investment involvement does CTI Life Sciences Fund have?
CTI Life Sciences Fund adds value to its portfolio companies through deep industry expertise, strategic guidance, and access to a robust network of partners and resources in the biotechnology sector. The team’s extensive experience enables them to support companies in navigating the complexities of the biotech landscape.
What is the fund size and check size range for CTI Life Sciences Fund?
CTI Life Sciences Fund manages a total of $345 million CAD across three funds, with a fund size of $258 million for its latest fund. The check sizes vary depending on the stage of investment, typically ranging from early-stage to more mature funding rounds.
Check your startup’s fit
Check your startup’s fit with CTI Life Sciences FundSimilar investors
Organizations that do similar work to CTI Life Sciences Fund.
Investor
InvestorCatalonia's gateway for foreign investment and startup support.
InvestorInnovative investment strategies for exceptional long-term returns.
InvestorAndreessen Horowitz, also known as a16z, is a prominent venture capital firm based in Silicon Valley, founded in 2009. The firm invests across various sectors, supporting companies from early-stage startups to growth-stage firms.
Superscout Pro
Find faster. Show up verified. Keep your deals private.
$99a year, or $12 a month
Get Pro- Search that narrowsInvestors, programs, accelerators, incubators and studios, by stage, sector and place.
- A verified profileThe people you reach know you are who you say you are.
- A private deal vaultThe startups you are watching, with your notes and your reasons. Nobody else's eyes.
Is this page right?Reviewed · How the research works